PT3049102T - Lactoferrina para o tratamento de ibd associadas a invasão bacteriana - Google Patents
Lactoferrina para o tratamento de ibd associadas a invasão bacterianaInfo
- Publication number
- PT3049102T PT3049102T PT147816763T PT14781676T PT3049102T PT 3049102 T PT3049102 T PT 3049102T PT 147816763 T PT147816763 T PT 147816763T PT 14781676 T PT14781676 T PT 14781676T PT 3049102 T PT3049102 T PT 3049102T
- Authority
- PT
- Portugal
- Prior art keywords
- lactoferrin
- treatment
- bacterial invasion
- ibd associated
- ibd
- Prior art date
Links
- 102000010445 Lactoferrin Human genes 0.000 title 1
- 108010063045 Lactoferrin Proteins 0.000 title 1
- 230000008952 bacterial invasion Effects 0.000 title 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 title 1
- 229940078795 lactoferrin Drugs 0.000 title 1
- 235000021242 lactoferrin Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Botany (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001578A ITMI20131578A1 (it) | 2013-09-25 | 2013-09-25 | Sostanza e formulazione per il trattamento delle malattie infiammatorie croniche intestinali |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3049102T true PT3049102T (pt) | 2020-06-01 |
Family
ID=49519039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT147816763T PT3049102T (pt) | 2013-09-25 | 2014-09-04 | Lactoferrina para o tratamento de ibd associadas a invasão bacteriana |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20160206707A1 (pt) |
| EP (1) | EP3049102B1 (pt) |
| CN (1) | CN105744947A (pt) |
| ES (1) | ES2794523T3 (pt) |
| HR (1) | HRP20200891T1 (pt) |
| IT (1) | ITMI20131578A1 (pt) |
| PL (1) | PL3049102T3 (pt) |
| PT (1) | PT3049102T (pt) |
| RS (1) | RS60357B1 (pt) |
| RU (1) | RU2689987C2 (pt) |
| WO (1) | WO2015044809A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111166872A (zh) * | 2020-02-24 | 2020-05-19 | 中国科学院昆明动物研究所 | 转铁蛋白在制备免疫抑制剂类药物中的应用 |
| CN111110834A (zh) * | 2020-02-24 | 2020-05-08 | 中国科学院昆明动物研究所 | 转铁蛋白或过表达转铁蛋白在制备治疗和/或预防溃疡性结肠炎的药物中的应用 |
| EP4137511A4 (en) | 2020-04-16 | 2024-01-10 | Dermopartners, S.L. | NEW COMPOSITION FOR USE IN THE TREATMENT AND PREVENTION OF INFECTIONS BY COVID19 AND OTHER CORONAVIRUS |
| EP4384148A1 (en) * | 2021-09-10 | 2024-06-19 | Univerza V Ljubljani | Enteric-coated particles containing lactoferrin |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60005819T2 (de) * | 1999-06-14 | 2004-05-06 | Cosmo S.P.A. | Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe |
| JP4592041B2 (ja) * | 2000-11-24 | 2010-12-01 | 株式会社Ｎｒｌファーマ | 生活の質を改善する新規食品の製造法および用途 |
| CA2461708C (en) * | 2001-09-28 | 2012-08-07 | Nutraceutix, Inc. | Delivery system for biological component |
| JP2006111558A (ja) * | 2004-10-14 | 2006-04-27 | Bioserentack Co Ltd | 多層構造を有する錠剤状の小腸粘膜付着性経口製剤 |
| EP1940454A4 (en) * | 2005-09-28 | 2012-01-04 | Ventria Bioscience | ORAL PREPARATION FOR ENTERIC DISORDERS AND / OR REHYDRATION |
| RU2418071C2 (ru) * | 2008-11-05 | 2011-05-10 | Государственное образовательное учреждение высшего профессионального образования "Астраханский государственный университет" (АГУ) | Способ получения бактериального лактоферрина |
| US20120171163A1 (en) * | 2010-12-29 | 2012-07-05 | Anja Wittke | Method for inhibiting a bacterial invasive mechanism using a nutritional composition |
-
2013
- 2013-09-25 IT IT001578A patent/ITMI20131578A1/it unknown
-
2014
- 2014-09-04 CN CN201480062587.7A patent/CN105744947A/zh active Pending
- 2014-09-04 RS RS20200646A patent/RS60357B1/sr unknown
- 2014-09-04 ES ES14781676T patent/ES2794523T3/es active Active
- 2014-09-04 EP EP14781676.3A patent/EP3049102B1/en active Active
- 2014-09-04 US US15/023,538 patent/US20160206707A1/en not_active Abandoned
- 2014-09-04 WO PCT/IB2014/064255 patent/WO2015044809A1/en active Application Filing
- 2014-09-04 PL PL14781676T patent/PL3049102T3/pl unknown
- 2014-09-04 RU RU2016115985A patent/RU2689987C2/ru active
- 2014-09-04 PT PT147816763T patent/PT3049102T/pt unknown
-
2020
- 2020-06-04 HR HRP20200891TT patent/HRP20200891T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2794523T3 (es) | 2020-11-18 |
| RU2016115985A (ru) | 2017-10-30 |
| ITMI20131578A1 (it) | 2015-03-26 |
| WO2015044809A1 (en) | 2015-04-02 |
| RU2689987C2 (ru) | 2019-05-30 |
| HRP20200891T1 (hr) | 2020-09-18 |
| PL3049102T3 (pl) | 2020-09-07 |
| US20160206707A1 (en) | 2016-07-21 |
| EP3049102B1 (en) | 2020-03-04 |
| RS60357B1 (sr) | 2020-07-31 |
| RU2016115985A3 (pt) | 2018-03-05 |
| EP3049102A1 (en) | 2016-08-03 |
| CN105744947A (zh) | 2016-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1225649A1 (zh) | 用於治療細菌性感染的化合物和方法 | |
| GB2528196B (en) | Multiple-qubit wave-activated controlled gate | |
| EP2991638A4 (en) | METHODS OF TREATING BACTERIAL INFECTIONS | |
| HK1218293A1 (zh) | 治療細菌感染的化合物和方法 | |
| SI3569294T1 (sl) | Od napihnjenosti neodvisna žoga z ovojem | |
| SG11201604537UA (en) | Implantable biosensor | |
| HK1215164A1 (zh) | 處理方法 | |
| PT3084009T (pt) | Lactobacillus salivarius para o tratamento da mastite | |
| GB201304872D0 (en) | Treatment | |
| GB2514334B (en) | Video processing | |
| PL3049102T3 (pl) | Laktoferyna do leczenia IBD związanych z inwazją bakteryjną | |
| HK1216391A1 (zh) | 組合治療 | |
| EP3069139A4 (en) | BACTERIAL DIAGNOSIS | |
| EP2966973A4 (en) | IMPROVED METHODS OF GRAIN PROCESSING WITH OZONE | |
| GB201305564D0 (en) | Microbial control | |
| EP3016207A4 (en) | Waterproof treatment structure for linear member | |
| EP2970860A4 (en) | GENETICALLY MODIFIED BACTERIA | |
| GB201411003D0 (en) | Coffin | |
| GB201307310D0 (en) | Treatment | |
| GB2514120B (en) | Video processing | |
| GB201321115D0 (en) | Treatment | |
| GB201301722D0 (en) | Quantifcation of bacteria | |
| GB201309238D0 (en) | Treatment | |
| PT2861214T (pt) | Lipossomas adaptados para o tratamento de infeções bacterianas | |
| HU4376U (en) | Closing structure with magnet |